The Global and United States Mumps Vaccine Market Report was published by QY Research recently.
Mumps Vaccine Market Analysis and Insights
This report focuses on global and United States Mumps Vaccine market, also covers the segmentation data of other regions in regional level and county level.
Mumps Vaccine market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Mumps Vaccine market will be able to gain the upper hand as they use the report as a powerful resource.
For United States market, this report focuses on the Mumps Vaccine market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Full Report Description, Table of Figure, Chart, Free sample, etc. please click
Segments Covered in the Report
Mumps Vaccine Market Segment by Type
Child
Adult
Mumps Vaccine Market Segment by Application
Hospitals Pharmacies
Retail Pharmacies
The report on the Mumps Vaccine market covers the following region analysis:
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
The report mentions the prominent market player consisting of:
MedImmune
Johnson & Johnson
Merck & Co., Inc.
Sanofi
Serum Institute of India
Bavarian Nordic
Astellas Pharma India
CSL Limited
Emergent BioSolutions
GlaxoSmithKline
Panacea Biotec, Ltd.
Biological E Limited
Bharat Biotech Ltd.
Novavax, Inc.
Novartis
Sinovac Biotech, Ltd.
Incepta Vaccine Limited
Valneva SE
VBI Vaccines
PT Bio Farma
Smart Factory
Key Objectives of This Report
To study and analyze the global Mumps Vaccine consumption (value & volume) by key regions/countries, type and application, history data from 2017 to 2022, and forecast to 2028.
To understand the structure of Mumps Vaccine market by identifying its various subsegments.
Focuses on the key global Mumps Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Mumps Vaccine with respect to individual growth trends, prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges, and risks).
To project the consumption of Mumps Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Key Topics Covered:
1 Study Coverage
2 Market by Type
3 Market by Application
4 Global Mumps Vaccine Competitor Landscape by Company
5 Global Mumps Vaccine Market Size by Region
5.1 Global Mumps Vaccine Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Mumps Vaccine Market Size in Volume by Region (2017-2028)
5.2.1 Global Mumps Vaccine Sales in Volume by Region: 2017-2022
5.2.2 Global Mumps Vaccine Sales in Volume Forecast by Region (2023-2028)
5.3 Global Mumps Vaccine Market Size in Value by Region (2017-2028)
5.3.1 Global Mumps Vaccine Sales in Value by Region: 2017-2022
5.3.2 Global Mumps Vaccine Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Mumps Vaccine Market Size YoY Growth 2017-2028
6.1.2 North America Mumps Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Mumps Vaccine Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Mumps Vaccine Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Mumps Vaccine Market Size YoY Growth 2017-2028
6.3.2 Europe Mumps Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Mumps Vaccine Market Size YoY Growth 2017-2028
6.4.2 Latin America Mumps Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.4.6 Colombia
6.5 Middle East and Africa
6.5.1 Middle East and Africa Mumps Vaccine Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Mumps Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 MedImmune
7.1.1 MedImmune Corporation Information
7.1.2 MedImmune Description and Business Overview
7.1.3 MedImmune Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.1.4 MedImmune Mumps Vaccine Products Offered
7.1.5 MedImmune Recent Development
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporation Information
7.2.2 Johnson & Johnson Description and Business Overview
7.2.3 Johnson & Johnson Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Johnson & Johnson Mumps Vaccine Products Offered
7.2.5 Johnson & Johnson Recent Development
7.3 Merck & Co., Inc.
7.3.1 Merck & Co., Inc. Corporation Information
7.3.2 Merck & Co., Inc. Description and Business Overview
7.3.3 Merck & Co., Inc. Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Merck & Co., Inc. Mumps Vaccine Products Offered
7.3.5 Merck & Co., Inc. Recent Development
7.4 Sanofi
7.4.1 Sanofi Corporation Information
7.4.2 Sanofi Description and Business Overview
7.4.3 Sanofi Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Sanofi Mumps Vaccine Products Offered
7.4.5 Sanofi Recent Development
7.5 Serum Institute of India
7.5.1 Serum Institute of India Corporation Information
7.5.2 Serum Institute of India Description and Business Overview
7.5.3 Serum Institute of India Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Serum Institute of India Mumps Vaccine Products Offered
7.5.5 Serum Institute of India Recent Development
7.6 Bavarian Nordic
7.6.1 Bavarian Nordic Corporation Information
7.6.2 Bavarian Nordic Description and Business Overview
7.6.3 Bavarian Nordic Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Bavarian Nordic Mumps Vaccine Products Offered
7.6.5 Bavarian Nordic Recent Development
7.7 Astellas Pharma India
7.7.1 Astellas Pharma India Corporation Information
7.7.2 Astellas Pharma India Description and Business Overview
7.7.3 Astellas Pharma India Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Astellas Pharma India Mumps Vaccine Products Offered
7.7.5 Astellas Pharma India Recent Development
7.8 CSL Limited
7.8.1 CSL Limited Corporation Information
7.8.2 CSL Limited Description and Business Overview
7.8.3 CSL Limited Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.8.4 CSL Limited Mumps Vaccine Products Offered
7.8.5 CSL Limited Recent Development
7.9 Emergent BioSolutions
7.9.1 Emergent BioSolutions Corporation Information
7.9.2 Emergent BioSolutions Description and Business Overview
7.9.3 Emergent BioSolutions Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Emergent BioSolutions Mumps Vaccine Products Offered
7.9.5 Emergent BioSolutions Recent Development
7.10 GlaxoSmithKline
7.10.1 GlaxoSmithKline Corporation Information
7.10.2 GlaxoSmithKline Description and Business Overview
7.10.3 GlaxoSmithKline Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.10.4 GlaxoSmithKline Mumps Vaccine Products Offered
7.10.5 GlaxoSmithKline Recent Development
7.11 Panacea Biotec, Ltd.
7.11.1 Panacea Biotec, Ltd. Corporation Information
7.11.2 Panacea Biotec, Ltd. Description and Business Overview
7.11.3 Panacea Biotec, Ltd. Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Panacea Biotec, Ltd. Mumps Vaccine Products Offered
7.11.5 Panacea Biotec, Ltd. Recent Development
7.12 Biological E Limited
7.12.1 Biological E Limited Corporation Information
7.12.2 Biological E Limited Description and Business Overview
7.12.3 Biological E Limited Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Biological E Limited Products Offered
7.12.5 Biological E Limited Recent Development
7.13 Bharat Biotech Ltd.
7.13.1 Bharat Biotech Ltd. Corporation Information
7.13.2 Bharat Biotech Ltd. Description and Business Overview
7.13.3 Bharat Biotech Ltd. Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Bharat Biotech Ltd. Products Offered
7.13.5 Bharat Biotech Ltd. Recent Development
7.14 Novavax, Inc.
7.14.1 Novavax, Inc. Corporation Information
7.14.2 Novavax, Inc. Description and Business Overview
7.14.3 Novavax, Inc. Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Novavax, Inc. Products Offered
7.14.5 Novavax, Inc. Recent Development
7.15 Novartis
7.15.1 Novartis Corporation Information
7.15.2 Novartis Description and Business Overview
7.15.3 Novartis Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Novartis Products Offered
7.15.5 Novartis Recent Development
7.16 Sinovac Biotech, Ltd.
7.16.1 Sinovac Biotech, Ltd. Corporation Information
7.16.2 Sinovac Biotech, Ltd. Description and Business Overview
7.16.3 Sinovac Biotech, Ltd. Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Sinovac Biotech, Ltd. Products Offered
7.16.5 Sinovac Biotech, Ltd. Recent Development
7.17 Incepta Vaccine Limited
7.17.1 Incepta Vaccine Limited Corporation Information
7.17.2 Incepta Vaccine Limited Description and Business Overview
7.17.3 Incepta Vaccine Limited Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Incepta Vaccine Limited Products Offered
7.17.5 Incepta Vaccine Limited Recent Development
7.18 Valneva SE
7.18.1 Valneva SE Corporation Information
7.18.2 Valneva SE Description and Business Overview
7.18.3 Valneva SE Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.18.4 Valneva SE Products Offered
7.18.5 Valneva SE Recent Development
7.19 VBI Vaccines
7.19.1 VBI Vaccines Corporation Information
7.19.2 VBI Vaccines Description and Business Overview
7.19.3 VBI Vaccines Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.19.4 VBI Vaccines Products Offered
7.19.5 VBI Vaccines Recent Development
7.20 PT Bio Farma
7.20.1 PT Bio Farma Corporation Information
7.20.2 PT Bio Farma Description and Business Overview
7.20.3 PT Bio Farma Mumps Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.20.4 PT Bio Farma Products Offered
7.20.5 PT Bio Farma Recent Development
Any questions or further requirements about the report, please click
https://us.qyresearch.com/reports/365584/mumps-vaccine
Customization of the Report:
This report can be customized to meet the client’s requirements. Please contact with us (global@qyresearch.com), who will ensure that you get a report that suits your needs.
Company Profiles:
QYResearch founded in California, USA in 2007. It is a leading global market research and consulting company. With over 15 years’ experience and professional research team in various cities over the world, QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let’s work closely with you and build a bold and better future.
Contact Us
QY Research
E-mail: global@qyresearch.com
Tel: +1-626-842-1666(US) +852-5808-0956 (HK)
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
Website: https://us.qyresearch.com